Hints and tips:
Related Special Reports
...Activist investors want to split the group’s pharmaceuticals business from its crop science unit to optimise its valuation....
...Last year, a number of UK companies, including veterinary pharmaceuticals company Dechra and the restaurant group behind Japanese dining chain Wagamama, were acquired by buyout firms....
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
...Thousands of international companies will still face pressure to meet the higher bar for climate risk information set by Europe, despite the wider gap in global standards created by the new lighter rules...
...Firms that have shorted the stock include London-based Marble Bar, CapeView Capital and Kuvari Partners....
...Several early-stage life sciences investors told the Financial Times the technology was attractive but that the field faced a higher bar for investment than other start-ups....
...All of this “substantially raises the bar for change at this time”, the proxy adviser said....
...“Always gold bars and Maotai [Chinese liquor] . . ....
...“These guys keep raising the bar as everyone else is trying to catch up,” said Emily Field, an analyst at Barclays....
...But it is not yet obvious it has cleared the bar in proving this counts as anti-competitive behaviour. richard.waters@ft.com...
...“We are very disappointed with the results,” said Merck’s global head of research and development and chief medical officer Danny Bar-Zohar, adding that the company would continue to “focus on progressing...
...He founded and later sold the companies Pharmaceutical Product Development, a contract research organisation, and Furiex Pharmaceuticals, whose leading product was a diarrhoea medication....
Rare step comes after Brussels fined US biotech for buying Grail without approval
...BAT’s Vuse vaping product has faced stiff competition from Chinese-owned brands Elf Bar and Lost Mary in drawing UK vapers....
Money for research will be required but salvation may come from a partnership with GSK
...She has just spent her breakfast being photographed in the hotel’s Bar Les Ambassadeurs for this magazine....
...That is still too high a bar for today’s technology. A third issue raised by the accident concerns regulation....
...There was a 15 per cent decline in the risk of death from cardiovascular causes specifically, though the numbers did not quite meet the bar for statistical significance....
...Smart reads China exit Wealthy Chinese are moving billions of dollars out of the country by buying everything from overseas luxury apartments to insurance policies and gold bars amid growing concerns about...
...In exchange for the contribution, the Sacklers insisted that the deal would permanently bar any civil lawsuits against them over Purdue’s alleged misdeeds — although it would not foreclose potential criminal...
The US trust buster’s opposition to the tie-up focuses on so-called pharmacy benefit managers
Proxy adviser says the two executives failed to take responsibility for destructive deal for Grail
World’s biggest gene sequencing group closed deal with cancer screening start-up despite ongoing investigation
...In second place, with five promotions and demotions, is Hikma Pharmaceuticals....
Antitrust challenge may force big pharma groups to rethink ‘pure play’ business models
International Edition